Our program is focused on interrelationships of nuclear structure and gene expression. That are functionally linked to modified transcriptional control in transformed and tumor cells. Our working hypothesis is that parameters of nuclear structure support cell growth and phenotypic properties of normal and tumor cells by facilitating the organization of chromosomes, genes, transcripts and regulators within the dynamic 3- dimensional context of nuclear architecture. Investigators at the University of Massachusetts Medical School have been instrumental in establishing the conceptual and experimental basis for multiple parameters of nuclear organization in gene regulation. Key contributions to the emerging recognition that structural components of the nucleus mediate transcription and the processing of gene transcripts have been provided by collaborations among our program project investigators. This team approach has advanced understanding of intranuclear trafficking of transcription factors to sites that support gene expression, the regulation of chromatin remodeling and chromosome segregation, the structural and functional properties of the nuclear matrix and characteristics of functional novel domains. We are committed to experimentally defining novel mechanisms that relate changes in nuclear morphology to aberrant growth in tumor cells from the perspective of perturbations in the subnuclear representation and targeting of nucleic acid and gene regulator proteins. Mechanisms by which nuclear structure integrates physiological regulatory signals that support gene expression are being addressed. We are investigating post- translational modifications of histones that support chromatin remodeling to render promoter elements accessible to transcription factors and facilitate synergism of activities at independent gene regulatory sequences. Regulation of centrosome organization is being pursued in relation to altered assembly of the mitotic apparatus, chromosome segregation and translocation, as well as aneuploidy in tumor cells. Our objective is to optimize the combination of cellular, biochemical and molecular approaches, together with in vitro and in vivo model systems, to define mechanisms by which nuclear architecture supports fidelity of gene expression. Equally important, we will gain insight into parameters of nuclear organization that are associated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA082834-05
Application #
6887725
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gallahan, Daniel L
Project Start
2001-02-01
Project End
2006-01-31
Budget Start
2005-02-01
Budget End
2006-01-31
Support Year
5
Fiscal Year
2005
Total Cost
$1,237,111
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Araya, Héctor F; Sepulveda, Hugo; Lizama, Carlos O et al. (2018) Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2. J Cell Biochem 119:8204-8219
Carver, Gary E; Locknar, Sarah A; Weaver, Donald L et al. (2018) Real-time detection of breast cancer at the cellular level. J Cell Physiol :
Tracy, Kirsten M; Tye, Coralee E; Ghule, Prachi N et al. (2018) Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer. Mol Cancer Res 16:587-598
Zaidi, Sayyed K; Fritz, Andrew J; Tracy, Kirsten M et al. (2018) Nuclear organization mediates cancer-compromised genetic and epigenetic control. Adv Biol Regul 69:1-10
Hong, Deli; Fritz, Andrew J; Finstad, Kristiaan H et al. (2018) Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor. Mol Cancer Res 16:1952-1964
Zaidi, Sayyed K; Nickerson, Jeffrey A; Imbalzano, Anthony N et al. (2018) Mitotic Gene Bookmarking: An Epigenetic Program to Maintain Normal and Cancer Phenotypes. Mol Cancer Res 16:1617-1624
Hong, Deli; Fritz, Andrew J; Zaidi, Sayyed K et al. (2018) Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity. J Cell Physiol 233:9136-9144
Farina, Nicholas H; Zingiryan, Areg; Vrolijk, Michael A et al. (2018) Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention. J Cell Physiol 233:6408-6417
Tracy, Kirsten M; Tye, Coralee E; Page, Natalie A et al. (2018) Selective expression of long non-coding RNAs in a breast cancer cell progression model. J Cell Physiol 233:1291-1299
Hong, Deli; Fritz, Andrew J; Gordon, Jonathan A et al. (2018) RUNX1-dependent mechanisms in biological control and dysregulation in cancer. J Cell Physiol :

Showing the most recent 10 out of 213 publications